Selected as an accepted participant by the DEA Administrative Law Judge to represent geriatric care and older adult health needs during proposed federal Schedule III rescheduling proceedings, Dr. Benjamin Caplan advocates for evidence-based cannabis policy under the Controlled Substances Act. Although the formal administrative hearings did not convene following subsequent federal procedural delays, the clinical imperative to transition cannabis away from Schedule I remains urgent. This comprehensive regulatory brief examines the statutory criteria for accepted medical use, economic impacts for Medicare beneficiaries, and physician perspectives on federal reform.